Cumulative Probability of Prostate Cancer Detection Using the International Prostate Symptom Score in a Prostate-specific Antigen-based Population Screening Program in Japan

Kitagawa, Yasuhide; Urata, Satoko; Narimoto, Kazutaka; Nakagawa, Tomomi; Izumi, Kouji; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio

추천

검색

자료유형: 학술저널

저자정보: Kitagawa, Yasuhide (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Urata, Satoko (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Narimoto, Kazutaka (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Nakagawa, Tomomi (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Izumi, Kouji (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Kadono, Yoshifumi (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Konaka, Hiroyuki (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Mizokami, Atsushi (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University) Namiki, Mikio (Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa Unive)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제17호

발행연도: 2014.1

수록면: 7,079 - 7,083 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

The International Prostate Symptom Score (IPSS) is often used as an interview sheet for assessing lower urinary tract symptoms (LUTS) at the time of prostate-specific antigen (PSA) testing during population-based screening for prostate cancer. However, the relationship between prostate cancer detection and LUTS status remains controversial. To elucidate this relationship, the cumulative probability of prostate cancer detection using IPSS in biopsy samples from patients categorized by serum PSA levels was investigated. The clinical characteristics of prostate cancer detected using IPSS during screening were also investigated. A total of 1,739 men aged 54-75 years with elevated serum PSA levels who completed the IPSS questionnaire during the initial population screening in Kanazawa City, Japan and underwent systematic transrectal ultrasonography-guided prostate biopsy between 2000 and 2013 were enrolled in the present study. Of the 1,739 men, 544 (31.3%) were diagnosed with prostate cancer during the observation period. The probability of cancer detection at 3 years in the entire study population was 27.4% and 32.7% for men with $IPSS{\leq}7$ and those with $IPSS{\geq}8$, respectively; there was no statistically significant difference between groups. In men with serum PSA levels of 6.1 to 12.0ng/mL at initial screening, the probability of cancer detection was significantly higher in men with $IPSS{\leq}7$ than in those with $IPSS{\geq}8$. There were no significant differences in clinical characteristics between groups of patients stratified by IPSS. These findings indicate that the use of IPSS for LUTS status evaluation may be useful for prostate cancer detection in the limited range of serum PSA levels.

#Prostate cancer #International Prostate Symptom Score #screening #risk factor

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Kitagawa, Yasuhide

소속기관 Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa U